News from Hyrax Biosciences

Recent articles

Analysis support for additional SARS-CoV-2 sequencing protocols

Dr. Kirsten Miller-Duys 29/07/2021

At Hyrax Biosciences we continue to support the surveillance efforts for SARS-COV-2, to be able to detect and monitor Variants of Concern (VoC) and Variants of Interest (VoI). Our software platform Exatype makes the data analysis for next generation sequencing (NGS) data a simple, automated step in the genotyping process.

Read full article Circled red down arrow

Your sequence data.
One solution.

Get in touch Email sending